Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NOW: Neoadjuvant Olaparib Window Trial in Newly Diagnosed BRCA-Mutant Ovarian Cancer

NCT03943173 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT03943173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03943173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NOW: Neoadjuvant Olaparib Window Trial in Newly Diagnosed BRCA-Mutant Ovarian Cancer
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
June 7, 2019
Completion date
June 27, 2027
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca-mutated ovarian carcinoma, brca1 gene mutation, brca2 gene mutation, high grade fallopian tube serous adenocarcinoma, high grade ovarian serous adenocarcinoma, primary peritoneal high grade serous adenocarcinoma, stage iii fallopian tube cancer ajcc v8, stage iii ovarian cancer ajcc v8, stage iii primary peritoneal cancer ajcc v8, stage iiia fallopian tube cancer ajcc v8, stage iiia ovarian cancer ajcc v8, stage iiia primary peritoneal cancer ajcc v8, stage iiia1 fallopian tube cancer ajcc v8, stage iiia1 ovarian cancer ajcc v8, stage iiia2 fallopian tube cancer ajcc v8, stage iiia2 ovarian cancer ajcc v8, stage iiib fallopian tube cancer ajcc v8, stage iiib ovarian cancer ajcc v8, stage iiib primary peritoneal cancer ajcc v8, stage iiic fallopian tube cancer ajcc v8, stage iiic ovarian cancer ajcc v8, stage iiic primary peritoneal cancer ajcc v8, stage iv fallopian tube cancer ajcc v8, stage iv ovarian cancer ajcc v8, stage iv primary peritoneal cancer ajcc v8, stage iva fallopian tube cancer ajcc v8, stage iva ovarian cancer ajcc v8, stage iva primary peritoneal cancer ajcc v8, stage ivb fallopian tube cancer ajcc v8, stage ivb ovarian cancer ajcc v8, stage ivb primary peritoneal cancer ajcc v8